Font Size:

On Demand March 5, 2008

Cardiometabolic Syndrome: Understanding Risk and Treatment

Broadcast Date: March 5, 2008 | (2 hours)


Myrtle E. Goore, MD (8 pages)
Beverly Stoudemire-Howlett, MD (11 pages, 1.1 MB)
Terri Klose, RN, RD (13 pages, 1.5 MB)

Choose Player

Windows Media Player

Program Overview

The growing prevalence of the cardiometabolic syndrome (CMS) has been related to obesity, which has increased among many age groups. It is currently accepted that CMS predicts cardiovascular mortality and/or the development of type 2 diabetes mellitus. CMS is further complicated by modifications in body composition and fat redistribution and is often associated with altered insulin sensitivity. The primary goal of clinical management of the metabolic syndrome is to reduce the risk for type 2 diabetes and cardiovascular disease.

For more information, view the conference flyer.

Target Audience

Physicians, nurse practitioners, nurses, physician assistants, pharmacists, dietitians and social workers.

Contact Hours

None for this program.

Contact for Technical Assistance

Call 334-206-5618 or email ALPHTN.

Alabama Public Health Training Network Home

Page last updated: May 13, 2021